Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity.
Saved in:
| Title: | Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity. |
|---|---|
| Authors: | Hill CS; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Sidney Kimmel Cancer Center, Baltimore, MD, USA., Rosati LM; University of South Carolina School of Medicine, Columbia, SC, USA., Hu C; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Sidney Kimmel Cancer Center, Baltimore, MD, USA., Fu W; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Sidney Kimmel Cancer Center, Baltimore, MD, USA., Sehgal S; Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA., Hacker-Prietz A; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Sidney Kimmel Cancer Center, Baltimore, MD, USA., Wolfgang CL; Department of Surgery, New York University Grossman School of Medicine, New York, NY, USA., Weiss MJ; Department of Surgery, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY, USA., Burkhart RA; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Hruban RH; Department of Pathology, the Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., De Jesus-Acosta A; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Le DT; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Zheng L; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Laheru DA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., He J; Department of Surgery, New York University Grossman School of Medicine, New York, NY, USA., Narang AK; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Sidney Kimmel Cancer Center, Baltimore, MD, USA. Anarang2@jhmi.edu., Herman JM; Radiation Medicine, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY, USA. Jherman1@northwell.edu. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2022 Apr; Vol. 29 (4), pp. 2456-2468. Date of Electronic Publication: 2022 Feb 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
